Media | Contact us

About us
Protecting our tomorrow
A firm focus on vaccines stands at the core of everything we do.
READ MORE
At a glance
Our Leadership Team
Business Ethics
Sustainability
What we do
From R&D to manufacturing
We are focused on the research, development and manufacturing of innovative life-saving vaccines
READ MORE
Products
Pipeline
INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more
News
Events & Presentations

Annual Report 2024
Financials
Governance

Stock information
Analysts
Annual General Meeting
Shareholder Portal
FAQ
Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE
Working With Us
Job Openings
Our Employees

Stock information

Stock Exchange	Nasdaq Copenhagen
Ticker symbol	BAVA
Reuters	BAVA.CO
Bloomberg	BAVA:DC
Year of IPO	1998
ISIN code	DK0015998017
Share capital	DKK 788,548,570
Number of shares	78,854,857
Nominal denomination	DKK 10
Share classes	One class
Voting rights	One share carries one vote